Table_3.xls (5.5 kB)
Clinicopathological changes in patients after anti-TNFα therapy.
dataset
posted on 2013-02-21, 03:41 authored by Elena Izquierdo, Juan D. Cañete, Raquel Celis, Begoña Santiago, Alicia Usategui, Raimon Sanmartí, Manuel J. del Rey, José L. PablosCD31+/aSMA–: immature vessels. CD31+/aSMA+: mature vessels. p-value of basal versus post-anti-TNF values.
(*)Absolute decrease from basal values in patients achieving moderate or good EULAR response (responders) and non responders to anti-TNF.